Is Roku Inc. (ROKU) A Smart Long-Term Buy?
Saga Partners, a fundamental, long-term, value investment management firm, published its fourth-quarter 2020 Investor Letter – a copy of which can be seen here. A net return of 24.5% was recorded by the fund for the Q4 of 2020, outperforming its S&P 500 benchmark that delivered a 12.1% return. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.
Saga Partners, in their Q4 2020 Investor Letter, said that Roku, Inc. (NASDAQ: ROKU) is one of the most attractive opportunities they currently own. Roku, Inc. is a TV entertainment streaming platform company that currently has a $56.8 billion market cap. For the past 3 months, ROKU delivered an impressive 92.28% return and settled at $469.70 per share at the closing of February 16th.
Is AstraZeneca (AZN) Stock a Buy For 2021?
Baron Health Care Fund recently published its fourth-quarter commentary – a copy of which can be downloaded here. During the fourth quarter of 2020, the Baron Health Care Fund returned 17.1% (institutional shares). In comparison, the benchmark S&P 500 Index was up 12.15%, while the Russell 3000 Health Care Index was up 10.08%. You should check out Baron’s top 5 stock picks for investors to buy right now, which could be the biggest winners of 2021.
In the Q4 2020 Investor Letter, Baron Health Care Fund highlighted a few stocks and AstraZeneca Plc (NASDAQ:AZN) is one of them. AstraZeneca Plc (NASDAQ:AZN) is a pharmaceutical company. In the last three months, AstraZeneca Plc (NASDAQ:AZN) stock lost 4.4% and on February 17th it had a closing price of $51.45. Here is what Baron Health Care Fund said:
Is Vertex Pharmaceuticals (VRTX) Stock a Buy For 2021?
Baron Health Care Fund recently published its fourth-quarter commentary – a copy of which can be downloaded here. During the fourth quarter of 2020, the Baron Health Care Fund returned 17.1% (institutional shares). In comparison, the benchmark S&P 500 Index was up 12.15%, while the Russell 3000 Health Care Index was up 10.08%. You should check out Baron’s top 5 stock picks for investors to buy right now, which could be the biggest winners of 2021.
In the Q4 2020 Investor Letter, Baron Health Care Fund highlighted a few stocks and Vertex Pharmaceuticals Inc (NASDAQ:VRTX) is one of them. Vertex Pharmaceuticals Inc (NASDAQ:VRTX) is a biopharmaceutical company. In the last three months, Vertex Pharmaceuticals Inc (NASDAQ:VRTX) stock gained 0.5% and on February 17th it had a closing price of $214.85. Here is what Baron Health Care Fund said:
Is Teladoc Health Inc. (TDOC) A Smart Long-Term Buy?
Saga Partners, a fundamental, long-term, value investment management firm, published its fourth-quarter 2020 Investor Letter – a copy of which can be seen here. A net return of 24.5% was recorded by the fund for the Q4 of 2020, outperforming its S&P 500 benchmark that delivered a 12.1% return. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.
Saga Partners, in their Q4 2020 Investor Letter, said that Teladoc Health, Inc. (NYSE: TDOC) is one of the most attractive opportunities they currently own. Teladoc Health, Inc. is a global telemedicine and virtual healthcare company that currently has a $12.6 billion market cap. For the past 3 months, TDOC delivered a -2.30% return and settled at $113.11 per share at the closing of February 16th.